Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
NCT06221852 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2025-11-05
Summary
This is a randomized, controlled clinical trial to assess the effects of the ketogenic diet in combination with treatment as usual on brain energy metabolism and psychiatric symptoms in individuals with first episode bipolar disorder and schizoaffective disorder.
Conditions
- Bipolar I Disorder
- Psychosis
- Schizoaffective Disorder
Interventions
- OTHER
-
Ketogenic diet
The ketogenic diet (KD) is a normo-caloric diet composed of high-fat, low carbohydrate, and adequate protein intake. The KD will consist of 3 meals a day plus snacks, targeting 75-80% fat, 13-18% protein, 7% carbohydrates.
- OTHER
-
Dietary Guidelines for Americans
Dietary Guidelines for Americans diet is a normo-caloric diet consisting of 3 meals a day plus snacks, emphasizing nutrient dense foods to meet food group needs (85% of calories), and limits foods and beverages higher in added sugars and saturated fat (15% of calories).
Sponsors & Collaborators
-
Baszucki Family Foundation
collaborator UNKNOWN -
Mclean Hospital
lead OTHER
Principal Investigators
-
Virginie-Anne Chouinard, MD · Mclean Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-12
- Primary Completion
- 2027-09-30
- Completion
- 2027-12-30
Countries
- United States
Study Locations
More Related Trials
-
Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling
NCT06748950 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar Illness
NCT05705063 ·Status: UNKNOWN ·Phase: NA
-
Brain Small Chain Fatty Acid Metabolism in Bipolar Disorder: Ketones
NCT06335875 ·Status: COMPLETED ·Phase: NA
-
Ketogenic Intervention for Bipolar Depression
NCT07121894 ·Status: RECRUITING ·Phase: NA
-
Healthy Lifestyles for Bipolar Disorder
NCT06188754 ·Status: RECRUITING ·Phase: NA
-
Open Study of the Neurobiological Effects of Intranasal Ketamine in Children and Adults With Bipolar Disorder
NCT05209217 ·Status: UNKNOWN
-
Time-Restricted Eating and Bipolar Disorder
NCT06105294 ·Status: TERMINATED ·Phase: NA
-
Ketosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderS
NCT06426134 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder
NCT05837104 ·Status: RECRUITING ·Phase: PHASE2
-
Dietary Intervention for Bipolar Disorder
NCT02272010 ·Status: COMPLETED ·Phase: NA
-
Healthy Lifestyles in Bipolar Disorder: Bay Area Study
NCT06555406 ·Status: RECRUITING ·Phase: NA
-
A Study of Elpipodect (MK-8189) in Participants With Bipolar I Disorder (MK-8189-020)
NCT06273774 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Ketamine and Lithium Therapy in Bipolar Depression
NCT01768767 ·Status: WITHDRAWN ·Phase: PHASE2
-
Bipolar Disorder Study for Men and Women
NCT00056277 ·Status: COMPLETED ·Phase: PHASE3
-
Time Restricted Eating (TRE) in Bipolar Disorder
NCT07211217 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder
NCT00035802 ·Status: COMPLETED ·Phase: PHASE3
-
A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder
NCT00035230 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania
NCT00393978 ·Status: COMPLETED ·Phase: PHASE4
-
Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder
NCT02855762 ·Status: COMPLETED ·Phase: NA
-
Prospective Metabolic Monitoring of Youth and Adults With Bipolar Disorder
NCT01282281 ·Status: COMPLETED
-
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder
NCT01822678 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Evaluation of the Antidepressant Effect of the Use of Probiotics in Bipolar Disorder
NCT05762887 ·Status: COMPLETED ·Phase: NA
-
Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
NCT03336918 ·Status: ACTIVE_NOT_RECRUITING
-
Cannabinoids in Bipolar Affective Disorder
NCT00397605 ·Status: WITHDRAWN ·Phase: NA
-
Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder
NCT03206463 ·Status: TERMINATED ·Phase: PHASE1